Suppr超能文献

具有人工智能功能的皮肤科移动应用程序的现状

Current State of Dermatology Mobile Applications With Artificial Intelligence Features.

作者信息

Wongvibulsin Shannon, Yan Matthew J, Pahalyants Vartan, Murphy William, Daneshjou Roxana, Rotemberg Veronica

机构信息

Division of Dermatology, David Geffen School of Medicine at the University of California, Los Angeles.

Department of Dermatology, New York University Grossman School of Medicine, New York, New York.

出版信息

JAMA Dermatol. 2024 Jun 1;160(6):646-650. doi: 10.1001/jamadermatol.2024.0468.

Abstract

IMPORTANCE

With advancements in mobile technology and artificial intelligence (AI) methods, there has been a substantial surge in the availability of direct-to-consumer mobile applications (apps) claiming to aid in the assessment and management of diverse skin conditions. Despite widespread patient downloads, these apps exhibit limited evidence supporting their efficacy.

OBJECTIVE

To identify and characterize current English-language AI dermatology mobile apps available for download, focusing on aspects such as purpose, supporting evidence, regulatory status, clinician input, data privacy measures, and use of image data.

EVIDENCE REVIEW

In this cross-sectional study, both Apple and Android mobile app stores were systematically searched for dermatology-related apps that use AI algorithms. Each app's purpose, target audience, evidence-based claims, algorithm details, data availability, clinician input during development, and data usage privacy policies were evaluated.

FINDINGS

A total of 909 apps were initially identified. Following the removal of 518 duplicates, 391 apps remained. Subsequent review excluded 350 apps due to nonmedical nature, non-English languages, absence of AI features, or unavailability, ultimately leaving 41 apps for detailed analysis. The findings revealed several concerning aspects of the current landscape of AI apps in dermatology. Notably, none of the apps were approved by the US Food and Drug Administration, and only 2 of the apps included disclaimers for the lack of regulatory approval. Overall, the study found that these apps lack supporting evidence, input from clinicians and/or dermatologists, and transparency in algorithm development, data usage, and user privacy.

CONCLUSIONS AND RELEVANCE

This cross-sectional study determined that although AI dermatology mobile apps hold promise for improving access to care and patient outcomes, in their current state, they may pose harm due to potential risks, lack of consistent validation, and misleading user communication. Addressing challenges in efficacy, safety, and transparency through effective regulation, validation, and standardized evaluation criteria is essential to harness the benefits of these apps while minimizing risks.

摘要

重要性

随着移动技术和人工智能(AI)方法的进步,直接面向消费者的移动应用程序(app)数量大幅增加,这些应用程序声称可协助评估和管理各种皮肤状况。尽管患者广泛下载,但这些应用程序显示出支持其疗效的证据有限。

目的

识别并描述当前可供下载的英文AI皮肤科移动应用程序,重点关注目的、支持证据、监管状态、临床医生意见、数据隐私措施以及图像数据的使用等方面。

证据审查

在这项横断面研究中,对苹果和安卓移动应用商店进行了系统搜索,以查找使用AI算法的皮肤科相关应用程序。评估了每个应用程序的目的、目标受众、基于证据的声明、算法细节、数据可用性、开发过程中的临床医生意见以及数据使用隐私政策。

研究结果

最初共识别出909个应用程序。去除518个重复项后,还剩下391个应用程序。随后的审查由于非医学性质、非英语语言、缺乏AI功能或不可用而排除了350个应用程序,最终仅留下41个应用程序进行详细分析。研究结果揭示了当前皮肤科AI应用程序领域的几个令人担忧的方面。值得注意的是,没有一个应用程序获得美国食品药品监督管理局的批准,只有2个应用程序包含因缺乏监管批准而发出的免责声明。总体而言,研究发现这些应用程序缺乏支持证据、临床医生和/或皮肤科医生的意见,并且在算法开发、数据使用和用户隐私方面缺乏透明度。

结论与意义

这项横断面研究确定,尽管AI皮肤科移动应用程序有望改善医疗服务的可及性和患者治疗效果,但就其当前状态而言,由于潜在风险、缺乏一致验证以及误导性的用户沟通,它们可能会造成危害。通过有效的监管、验证和标准化评估标准来应对疗效、安全性和透明度方面的挑战对于利用这些应用程序的益处同时将风险降至最低至关重要。

相似文献

6
Mobile applications in dermatology.皮肤病学中的移动应用程序。
JAMA Dermatol. 2013 Nov;149(11):1300-4. doi: 10.1001/jamadermatol.2013.5517.

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验